Clinical trial
Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or…
NCT00143533 · St. Jude Children's Research Hospital, Other · Completed
Key facts
| NCT number | NCT00143533 |
|---|---|
| Title | Prevention of Diarrhea in Patients Taking IV Irinotecan for Relapsed or Difficult to Treat Pediatric Solid Tumors |
| Official title | Phase I Study of Intravenous Irinotecan Using Selective Gastrointestinal Decontamination for Prevention of Diarrhea in Relapsed or Refractory Pediatric Solid Tumors |
| Lead sponsor | St. Jude Children's Research Hospital, Other |
| Collaborators | National Institutes of Health (NIH) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neoplasm, Diarrhea |
| Intervention type | Drug |
| Interventions | Irinotecan, Cefpodoxime |
| Enrollment | 20 |
| Start date | Sep 1, 2003 |
| Primary completion | Sep 1, 2010 |
| Completion | Jun 1, 2011 |
| First posted | Sep 2, 2005 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: